lobbying_activities: 748039

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
748039	34c4d2eb-cb19-4032-885c-9c6eb989d5c6	Q1	TIMMONS AND COMPANY, INC.	38164	TEVA PHARMACEUTICALS USA INC	2009	first_quarter	LBR	H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.	HOUSE OF REPRESENTATIVES,SENATE	100000		0	0	2009-04-13T15:09:30-04:00